To include your compound in the COVID-19 Resource Center, submit it here.

Entereg alvimopan: Phase III

ADLR completed enrollment in a double-blind, placebo-controlled Phase III study

Read the full 108 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE